| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/25/2003 | US6525020 For drug delivery |
| 02/20/2003 | WO2003014111A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014098A1 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 02/20/2003 | WO2003014097A1 Arylsulfonyl derivatives with 5-ht6 receptor affinity |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2002085871A3 Serotonergic agents with long-acting in vivo effects |
| 02/20/2003 | WO2002068399B1 Aryl carbamate derivatives, preparation and use thereof |
| 02/20/2003 | WO2002048097B1 Compounds, compositions and methods for treatment of parasitic infections |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036558 Useful in the treatment of chronic complications arising from diabetes, such as neuropathy; may also contain an angiotensin converting enzyme inhibitor. |
| 02/20/2003 | US20030035784 Hair condition |
| 02/20/2003 | DE20217957U1 Oxidative dyeing agent for keratin fibers uses 2-aminomethylene-substituted resorcinols as couplers, some of which are novel compounds |
| 02/20/2003 | CA2456250A1 Arylsulfonyl derivatives with 5-ht6 receptor affinity |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/19/2003 | EP1284262A1 Process for the preparation of cis-2,6-dimethylpiperazine |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283823A1 Novel mmp-2/mmp-9 inhibitors |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CN1398247A Colchinol derivatives as vascular damaging agents |
| 02/19/2003 | CN1397554A Novel N-benzyl diethylenediamine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1397547A Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 02/19/2003 | CN1101807C 异羟肟酸衍生物 Hydroxamic acid derivatives |
| 02/18/2003 | US6521755 Process for preparing 10,11-methanobenzosuberane derivatives |
| 02/18/2003 | US6521707 (poly)ether amine ester isocyanate derivatives that can be reacted with hydroxy and amino compounds to form urethanes or ureas used in the isolation of nucleic acids |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521619 Bind to the interaction-domain of integrin lfa-1 interrupting enothelial cell-leukocyte adhesion |
| 02/14/2003 | WO2002018326A1 Novel propenohydroxamic acid derivatives |
| 02/14/2003 | CA2423733A1 Novel propenohydroxamic acid derivatives |
| 02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | WO2003011844A2 Reagent and method for perfluoroalkylation |
| 02/13/2003 | WO2003011817A1 1, 3, 5-tricyano-2, 4, 6-tris(vinyl)benzene derivatives and method for preparing the same |
| 02/13/2003 | WO2003011296A1 Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient |
| 02/13/2003 | WO2003011282A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/13/2003 | WO2002096855A3 Anticholinergic compounds and methods of use |
| 02/13/2003 | US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032641 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 02/13/2003 | CA2455858A1 Pharmaceutical preparations containing aminobenzene- sulfonic acid derivatives as the active ingredient |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | CA2448235A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 02/12/2003 | EP1283039A1 -secretase inhibitors |
| 02/12/2003 | EP1282630A1 Hydroxylamine esters as polymerization initiators |
| 02/12/2003 | EP1282611A1 Substituted phenylacetamides and their use as glucokinase activators |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282597A1 Method for the production of $g(v)-aminoalkylsulphonic acids |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | CN1396916A Process for preparation of quetiapine and intermediates therefor |
| 02/12/2003 | CN1101397C Preparation of beta-methyl carbepenem intermediate |
| 02/11/2003 | US6518458 (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy |
| 02/11/2003 | US6518314 Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518272 HT3 receptor agonists and antagonists; treatment of anxiety, depression, cognitive deficits, and prostate cancer |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6517811 Compounds for cancer imaging and therapy |
| 02/06/2003 | WO2003010128A2 Perfluoroalkyl-substituted amines, acids, amino acids and thioether acids |
| 02/06/2003 | WO2003009897A1 Medicament inhibiting sodium/calcium exchange system |
| 02/06/2003 | WO2003009849A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2002032871A3 Compounds and methods for treating multidrug resistance |
| 02/06/2003 | US20030028026 Nitrate salts of Salbutamol, Cetirizine, Loratadine, Terfenadine, Emedastine, Ketotifen, Nedocromil, Ambroxol, Dextromethorphan, Dextorphan, Isoniazide, Erythromycin, and Pyrazinamide; respiratory system pathology treatment |
| 02/06/2003 | US20030027862 Amino-and amido-diphenyl ethers |
| 02/06/2003 | US20030027840 Estrogen receptor modulators |
| 02/06/2003 | US20030027832 4-Phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 02/06/2003 | US20030027831 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases |
| 02/06/2003 | US20030027822 Sodium channel modulators |
| 02/06/2003 | US20030026521 Optical interleaver |
| 02/06/2003 | CA2454903A1 Substituted piperazines as modulators of the melanocortin receptor |
| 02/06/2003 | CA2454681A1 Medicament inhibiting sodium/calcium exchange system |
| 02/06/2003 | CA2454564A1 Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1280785A1 Phenylsulphonylpiperazinyl derivatives as 5-ht receptor ligands |
| 02/05/2003 | EP1280764A2 Inhibitors of histone deacetylase |
| 02/05/2003 | EP1086078B1 Neuropeptide y5 receptor antagonists |
| 02/05/2003 | EP1082121A4 Hiv integrase inhibitors |
| 02/05/2003 | CN1395562A Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 02/05/2003 | CN1395467A Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 02/05/2003 | CN1394846A Alpha-substituted benzene acetic acid its preparation and farm pesticide containing said compound |
| 02/05/2003 | CN1100774C Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents |
| 02/05/2003 | CN1100767C Macrocyclic metal complex carboxylic acids, use and method for production thereof |
| 02/05/2003 | CN1100748C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substituted phenyl)-4-oxobutyric acids |
| 02/04/2003 | US6515180 Method for the catalytic, symmetric disubstitution of carboxylic acid amides with grignard reagents |
| 02/04/2003 | US6515028 Glucamine compounds for treating hepatitis virus infections |
| 02/04/2003 | US6515027 Substituted benzanilides as CCR5 receptors ligands, antiinflammatory agents and antiviral agents |
| 02/04/2003 | US6515024 Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 02/04/2003 | US6514976 Arylpiperazines having activity at the serotonin 1A receptor |
| 02/04/2003 | US6514975 Anti-inflammatory piperazinyl-benzyl-tetrazole derivatives and intermediates thereof |
| 02/04/2003 | US6514934 For treating sexual dysfunctions in males and females |
| 02/04/2003 | CA2272927C Dimesylate salts of neuropeptide y ligands |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 01/31/2003 | WO2002012169A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/31/2003 | CA2417880A1 Amino diphenyl ethers and amido diphenyl ethers |
| 01/30/2003 | WO2003008559A2 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders |
| 01/30/2003 | WO2003008399A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |